Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ramos

Showing results (561-570 of 606) with videos related to

Pageof 61
Sort By:
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against <i>Leishmania infantum</i> infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Cellular Immunology|August 23, 2020
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
International Journal of Spine Surgery|April 27, 2024
Polytomous Rasch Analyses of Surgeons' Decision-Making on Choice of Procedure in Endoscopic Lumbar Spinal Stenosis Decompression SurgeriesKai-Uwe Lewandrowski, Rossano Kepler Alvim Fiorelli, Mauricio G Pereira, et al.
JAMA Psychiatry|March 5, 2025
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression: A Randomized Clinical TrialMatheus Rassi F Ramos, Stephan Goerigk, Valquiria Aparecida da Silva, et al.
Molecular Immunology|February 2, 2023
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasisDaniela P Lage, Amanda S Machado, Camila S Freitas, et al.
Vaccines|July 27, 2022
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against <i>Leishmania infantum</i> InfectionDaniela P Lage, Danniele L Vale, Flávia P Linhares, et al.
Leukemia Research|April 11, 2022
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteriaA Triguero, B Xicoy, L Zamora, et al.
Experimental Parasitology|March 21, 2024
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis speciesIsabela A G Pereira, Camila S Freitas, Raquel S B Câmara, et al.
Cytokine|February 19, 2024
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasisCamila S Freitas, Isabela A G Pereira, Daniela P Lage, et al.
Human Genomics|June 12, 2026
Screening of autoinflammatory genes in patients with SARS-CoV-2-associated MIS-CRaquel Bispo São Pedro, Sâmek D Novaes, Thaís M M Barreto, et al.
Pageof 61

Showing results (561-570 of 606) with videos related to

Sort By:
Pageof 61
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against <i>Leishmania infantum</i> infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Cellular Immunology|August 23, 2020
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
International Journal of Spine Surgery|April 27, 2024
Polytomous Rasch Analyses of Surgeons' Decision-Making on Choice of Procedure in Endoscopic Lumbar Spinal Stenosis Decompression SurgeriesKai-Uwe Lewandrowski, Rossano Kepler Alvim Fiorelli, Mauricio G Pereira, et al.
JAMA Psychiatry|March 5, 2025
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression: A Randomized Clinical TrialMatheus Rassi F Ramos, Stephan Goerigk, Valquiria Aparecida da Silva, et al.
Molecular Immunology|February 2, 2023
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasisDaniela P Lage, Amanda S Machado, Camila S Freitas, et al.
Vaccines|July 27, 2022
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against <i>Leishmania infantum</i> InfectionDaniela P Lage, Danniele L Vale, Flávia P Linhares, et al.
Leukemia Research|April 11, 2022
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteriaA Triguero, B Xicoy, L Zamora, et al.
Experimental Parasitology|March 21, 2024
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis speciesIsabela A G Pereira, Camila S Freitas, Raquel S B Câmara, et al.
Cytokine|February 19, 2024
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasisCamila S Freitas, Isabela A G Pereira, Daniela P Lage, et al.
Human Genomics|June 12, 2026
Screening of autoinflammatory genes in patients with SARS-CoV-2-associated MIS-CRaquel Bispo São Pedro, Sâmek D Novaes, Thaís M M Barreto, et al.
Pageof 61